The Anti-Kickback Statute should be broadly interpreted as a bar to any kind of payment in exchange for health care services paid for by the government, the U.S. Attorney’s Office in Philadelphia argued in a qui tam suit brought against a pharmaceutical company called Allergan.
Among its arguments that the suit—brought under the Anti-Kickback Statute and the False Claims Act—should be dismissed, Allergan said the programs and services it had offered to physicians were speech that would be protected by the First Amendment.
